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Background: Klebsiella pneumoniae is a frequent nosocomial pathogen, with the multidrug-resistant (MDR)
K. pneumoniae being a major public health concern, frequently causing difficult-to-treat infections worldwide. The
aim of this study was to investigate the molecular characterization of clinical MDR Klebsiella pneumoniae isolates.
Methods: A total of 27 non-duplicate MDR K. pneumoniae isolates with a CTX-CIP-AK resistance pattern were
investigated for the prevalence of antimicrobial resistance genes including extended spectrum β-lactamase genes
(ESBLs), plasmid-mediated quinolone resistance (PMQR) genes, 16S rRNA methylase (16S-RMTase) genes, and
integrons by polymerase chain reaction (PCR) amplification and DNA sequencing. Plasmid replicons were typed
by PCR-based replicon typing (PBRT). Multi-locus sequence typing (MLST) and pulsed-field gel electrophoresis
(PFGE) were carried out to characterize the strain relatedness.
Results: All the isolates co-harbored 3 or more resistance determinants. OqxAB, CTX-M-type ESBLs and RmtB were
the most frequent determinants, distributed among19 (70.4%),18 (66.7%) and 8 (29.6%) strains. Fourteen isolates
harbored class 1 integrons, with orfD-aacA4 being the most frequent gene cassette array. Class 3 integrons were
less frequently identified and contained the gene cassette array of blaGES-1-blaOXA-10-aac(6′)-Ib. IncFII replicon was
most commonly found in this collection. One cluster was observed with ≥80% similarity among profiles obtained
by PFGE, and one sequence type (ST) by MLST, namely ST11, was observed in the cluster.
Conclusion: K. pneumoniae carbapenemase (KPC)–producing ST11 was the main clone detected. Of particular
concern was the high prevalence of multiple resistance determinants, classs I integrons and IncFII plasmid replicon
among these MDR strains, which provide advantages for the rapid development of MDR strains.
Keywords: Multidrug resistance, Resistance determinants, Multi-locus sequence typing, Pulsed-field gel
electrophoresis, Plasmid repliconsBackground
Klebsiella pneumoniae is an opportunistic pathogen as-
sociated with both community-acquired and nosocomial
infections, including pneumonia, urinary tract infections,
septicemia and wound infections, with the increasingly
multidrug-resistant (MDR) K. pneumoniae being a major
public health concern.
The prevailing hypothesis is that these bacteria acquire
multidrug resistance through horizontal transfer of anti-
microbial resistance genes mediated by mobile genetic
elements such as integrons [1]. Several genes that are fre-
quently involved in multidrug resistance to commonly* Correspondence: zhangkui6103@163.com
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olone resistance (PMQR) genes [2], exogenously acquired
16S rRNA methyltransferase (16S-RMTase) genes [3], and
extended-spectrum β-lactamases (ESBLs) encoding genes
[4]. Furthermore, carbapenem-hydrolyzing β-lactamases
(CHβLs) has rapidly emerged in recent years, with K.
pneumoniae being the most common organism associated
with K. pneumoniae carbapenemase (KPC) resistance de-
terminants [5].
Although the high prevalence of these resistance deter-
minants has been reported among MDR K. pneumoniae
strains [6,7], there is little information available on the
distribution of integrons and plasmid replicons among
these strains, and limited data on the genetic relation-
ship between these strains.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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prevalence of frequently reported antimicrobial resist-
ance determinants among the 27 clinical MDR K. pneu-
moniae isolates, to explore the distribution of integrons
and plasmid replicons, as well as to analyze the genetic
clonality by pulse field gel electrophoresis (PFGE) and
multi-locus sequence typing (MLST).
Method
Bacterial isolates
A total of 27 non-duplicate MDR K. pneumoniae isolates
simultaneously displaying resistance to cefotaxime, ami-
kacin and levofloxacin were collected from our hospitals
from March to July 2011(Susceptibility to antimicrobial
agents was determined using Kirby–Bauer’s disc diffu-
sion method and the results were analyzed and inter-
preted according to CLSI guidelines [8]). Among them,
12 strains were resistant to imipenem. The clinical sources
of these specimens include sputum (n = 13), urine (n = 4),
blood (n = 7), and wound secretions (n = 3). Among these
27 isolates, 2 strains originated from community-acquired
infections, defined as the pathogen being isolated within
48 h after hospital admittance. The other 25 ones were
from nosocomial infections, where the pathogens were
isolated more than 48 h after being admitted to a hospital.
Detection of antimicrobial resistance determinants
DNA templates were prepared by the boiling method. All
the isolates were analyzed for the presence of blaESBLs
(blaCTX, blaTEM, blaSHV, blaVEB, and blaOXA) [9],
PMQRs (qnrA, qnrB, qnrC, qnrD, qnrS, aac (6′)-Ib-cr, and
qepA) [10], and 16S-RMTases (armA, npmA, rmtA, rmtB,
rmtC, rmtD, and rmtE) [11]. The 12 strains resistant to
imipenem were further analyzed for CHβLs endocing
genes (blaKPC, blaOXA-48, blaIMP, blaVIM, blaNDM,
blaDIM, blaSPM, and blaSIM) [12]. All genes were
screened by multiplex PCR followed by single PCR for
gene confirmation. Positive products were further purified
with a DNA purification kit and then sent to the Majorbio
Company (Shanghai, China) for sequencing. Sequences
were analyzed by using the Chromas-Pro application and
BLAST (www.ncbi.nlm.nih.gov/BLAST).
Detection of integrons
Integrons were detected by PCR amplification of class 1,
2, and 3 integrase-specific int-1, int-2, and int-3 genes,
as described previously [13]. To reveal the gene cassettes
of the variable region of integrons, the variable region of
class 1 and 3 integrons were further amplified and puri-
fied, and then sequenced to determine their gene cas-
sette composition. The resulting nucleotide sequences
and deduced protein sequences were analyzed with the
BLAST and FASTA programs of the National Center for
Biotechnology Information (www.ncbi.nlm.nhi.gov).PCR-based replicon typing
Main plasmid incompatibility groups including F, FIA,
FIB, FIC, HI1, HI2, I1-Ic, L/M, N, P, W, T, A/C, K, B/O, X,
Y, and FII were determined using the PCR-based replicon
typing (PBRT) scheme as described by Carattoli [14].
Pulsed-field gel electrophoresis
Clonal relatedness of 27 K. pneumoniae isolates was ana-
lyzed by pulsed-field electrophoresis (PFGE) as described
[15]. Prepared genomic DNA was digested using the re-
striction endonuclease XbaI (Fermentas, ABI, Germany),
and DNA fragments were separated in a PFGE CHEF-DR
III system (Bio-Rad Laboratories, Hercules, CA) in 0.5×
Tris-borate-EDTA buffer at 120 V for 19 h, with pulse
times ranging from 2.2 s to 54.2 s. The banding patterns
were analyzed by the BioNumerics software (Applied
Math, Sint-Maten-Latem, Belgium). Cutoff lines at 65%
and 80% were used to analyze genetic relatedness.
Multi-locus sequence typing
Genotyping for the 27 MDR strains was further deter-
mined by multi-locus sequence typing (MLST) analysis.
MLST with 7 genes (gapA, infB, mdh, pgi, phoE, rpoB,
and tonB) was performed according to Diancourt et al.
[16]. Alleles and sequence types (STs) were assigned by
using the MLST database (www.pasteur.fr/mlst/Kpneu-
moniae.html).
Results
Wide distribution of resistance determinants
Diverse resistance determinants were found among the
MDR strains (Figure 1). β-Lactamse including CTX-M-
type ESBLs, sulfhydryl variable (SHV) variants, TEM-1b,
KPC, and OXA, were carried by 18 (66.7%), 15 (55.6%),
13 (48.1%), 15 (55.6%), 12 (44.4%), and 10 (37.0%) of
the isolates, respectively. PMQRs were detected in 21
isolates. Of these, 19 (70.4%) belonged to OqxAB, 11
(40.7%) to Qnr (7 QnrS1, 1 QnrB2, and 4 QnrB4), 10
(37.0%) to AAC (6′)-Ib-cr, and 1 to QepA. Determinants
conferring resistance to amikacin included 15 (55.6%)
16S-RMTase determinants, with RmtB being present in
29.6% (8/27), ArmA in 25.9% (7/27), AAC(6′)-Ib-cr in
10 (37.0%), and AAC(6′)-Ib in 10 (37.0%) (encoded by
10 aacA4 located within class 1 integron).
Furthermore, all the isolates co-harbored 3 or more re-
sistance determinants. The PMQRs were present in 19
out of the 22 ESBL-carrying K. pneumoniae isolates. Of
the 11 KPC-positive MDR K. pneumoniae isolates, 7 co-
carried rmtB or armA.
Prevalence of integrons
Integron analysis showed that 14 isolates carried class 1
integrons; 6 carried class 3 integrons; and 2 contained


































































































































































Figure 1 Dendrogram based on pulse-field gel electrophoresis developed in BioNumerics for 27 clinically multidrug-resistant Klebsiella
pneumoniae isolates. Ss, specimens; Int, integron; STs, sequence types; RTs, resistance determinants; RRs, plasmid replicons.
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positive strains revealed that the cassette arrays of class
1 integron include orfD-aacA4 (n = 10 strains) and
aad5-dfrA17 (n = 4 strains). Moreover, the variable re-
gions in class 3 integrons of all the 6 isolates were the
same as those comprising blaGES-1-blaOXA-10-aac(6′)-Ib,
which has been identified in an earlier study [17].Distribution of plasmid replicons
PBRT revealed that IncFII type was the predominant
plasmid replicon among the MDR K. pneumoniae strains
(Figure 1), IncFII (18/27, 66.7%), IncA/C (6/27, 22.2%)
and IncI1 (2/27, 7.4%) were found alone or in combin-
ation; IncN(4/27, 14.8%), IncFIC (2/27, 7.4%), IncY(1/27,
3.7%), IncFIB (1/27, 3.7%) and IncB/O (1/27, 3.7%) were
found in combination with IncFII.Clonal relatedness
According to the PFGE patterns of the isolates (Figure 1),
27 different clonal patterns were observed among the 27
MDR K. pneumoniae isolates with ≥65% similarity.
One cluster of 7 closely related isolates was found that
exhibited ≥80% similarities, these isolates were identified
to be ST11 clones.Sequence types for the K. pneumoniae isolates
MLST was conducted to determine the extent of geno-
typic diversity among the K. pneumoniae isolates. Fifteen
different STs were identified. The most dominant ST
was ST11 (29.6%, 8/27), followed by ST686 (14.8%, 4/
27), ST1 (7.4%, 2/27), ST756 (7.4%, 2/27). These 4 STs
accounted for 59.3% (16/27) of the total isolates. Among
the STs identified, ST415, ST186, ST276, and ST866
have previously not been identified to be MDR strains.Discussion
MDR K. pneumoniae strains have caused major thera-
peutic problems worldwide. The increasing prevalence
of clinical MDR isolates has been associated with higher
morbidity and mortality rates, posing a considerable
threat to public health. In this study, we provide the
current data on the molecular characterization of MDR
K. pneumoniae isolates isolated from different clinical
samples of hospitalized patients.
Our study revealed a wide distribution of diverse re-
sistance determinants among the MDR K. pneumoniae
strains. The most prevalent determinants were oqxAB
genes, which have been reported to be the most frequent
PMQRs in K. pneumoniae isolates [18]. CTX-M has
been found to be widely disseminated among clinical
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moniae [19], the even higher prevalence of blaCTX-M
among our strains corresponds with an earlier report
showing that CTX-M–producing strains are generally
MDR ones [19]. Furthermore, in line with the previous
investigation [20], KPC is highly prevalent among our
strains, which also demonstrated that the production of
KPC-type carbapenemases was the most prevalent car-
bapenem resistance mechanism in K. pneumoniae iso-
lates. In addition, the widely distributed 16S-RMTase
encoding genes in our MDR strains have been previously
reported in China [21], together with AAC (6′)-Ib-cr
and AAC (6′)-Ib accounting for the amikacin resistance.
Recently, co-production of 16S rRNA methylases (ArmA
and RmtB) and KPC were frequently reported in Entero-
bacteriaceae [22], which was also observed in our study,
leading to few choices for antimicrobial treatment. Not-
ably, there seems to be an intimate association between
the occurrence of oqxAB and ESBLs; a similar
phenomenon was noted for 16S-RMTase and β-
lactamase. Such a frequent co-existence of 16S-RMTase
with PMQRs and β-lactamase among MDR K. pneumo-
niae isolates in our study suggests a horizontal dissemin-
ation of these determinants amongst clinical MDR K.
pneumoniae isolates. These MDR strains co-carrying di-
verse and numerous multiple resistance determinants
may impose limitations in the therapeutic options avail-
able for the treatment of infections.
Epidemic resistance plasmids including IncFII, IncA/
C, IncL/M, IncN and IncI1 plasmids has been worldwide
detected in Enterobacteriaceae of different origin and
sources [23]. In our study, the wide distribution of IncFII
plasmid replicon is in accordance with the previous
studies showing that IncFII plasmid replicons were most
frequently detected in CTX-M-producing enterobacterial
isolates in China and in Europe [24,25]. Furthermore,
other plasmid replicons such as IncN, IncI1, IncY and
IncA/C distributed among our strains have also been
previously reported [26,27]. Additionally, the widely
prevalent IncFII plasmid replicons and class I integrons
identified in our study indicate that they might be play-
ing an important role in attributing MDR to the clinical
K. pneumoniae isolates. It is noteworthy that class 3 inte-
grons were also detected among our strains. which is also
reported earlier by Qi et al. in 2011 [28], showing the pres-
ence of class 3 integrons in MDR K. pneumoniae isolates
from clinical settings in China, since class 3 integrons have
also been found and characterized in Europe [29].
The genetic diversity of our isolates revealed that most
isolates were of different strains, indicating the ease of
transmission of these resistance determinants between
bacterial species by mobile elements. This has been par-
tially confirmed by the high prevalence of integrons and
plasmid replicons in our study. However, it seems thatthe epidemic dissemination of the major clone ST11
producing blaKPC also played an additional role in our
study, this corresponds with the report that ST11 is a
truly international sequence type and associated with
KPC [30]. Which is partly different from the KPC-
producing K. pneumoniae clonal complex 258 (ST258,
ST512, and ST101) in Europe and USA [31,32]. Of note,
the other STs such as ST415, ST186, ST276, and ST866
have not been previously identified to be MDR clones.
Such a high heterogeneity of ST clones observed may
further indicate the role of plasmids and integrons in the
development of clinical MDR isolates.
Conclusion
In summary, our study showed that clinical MDR K.
pneumoniae isolates may result mainly from the hori-
zontal dissemination of multiple resistance determinants
and the clonal dissemination of MDR ST11 strains–
producing KPC-2, which alerts us the emergency and
necessity to vigorously implement the infection control
practice to prevent the dissemination of these MDR iso-
lates in the healthcare settings.
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